User profiles for Pranav Gupta

Pranav Gupta

- Verified email at einsteinmed.org - Cited by 3883

Pranav Gupta

- Verified email at msm.edu - Cited by 428

Pranav Gupta

- Verified email at apple.com - Cited by 202

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

RJ Kathawala, P Gupta, CR Ashby Jr, ZS Chen - Drug resistance updates, 2015 - Elsevier
ATP-binding cassette (ABC) transporters represent one of the largest and oldest families of
membrane proteins in all extant phyla from prokaryotes to humans, which couple the energy …

[HTML][HTML] Precision wearable accelerometer contact microphones for longitudinal monitoring of mechano-acoustic cardiopulmonary signals

P Gupta, MJ Moghimi, Y Jeong, D Gupta, OT Inan… - NPJ digital …, 2020 - nature.com
Mechano-acoustic signals emanating from the heart and lungs contain valuable information
about the cardiopulmonary system. Unobtrusive wearable sensors capable of monitoring …

The development of anticancer ruthenium (II) complexes: from single molecule compounds to nanomaterials

L Zeng, P Gupta, Y Chen, E Wang, L Ji… - Chemical Society …, 2017 - pubs.rsc.org
Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer
drugs are organic molecules, while metallodrugs are very scarce. The advent of the first …

Modulating ROS to overcome multidrug resistance in cancer

Q Cui, JQ Wang, YG Assaraf, L Ren, P Gupta… - Drug Resistance …, 2018 - Elsevier
The successful treatment of cancer has significantly improved as a result of targeted therapy
and immunotherapy. However, during chemotherapy, cancer cells evolve and can acquire “…

[HTML][HTML] Voruciclib, a potent CDK4/6 inhibitor, antagonizes ABCB1 and ABCG2-mediated multi-drug resistance in cancer cells

P Gupta, YK Zhang, XY Zhang, YJ Wang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: The overexpression of ATP-Binding Cassette (ABC) transporters has known
to be one of the major obstacles impeding the success of chemotherapy in drug resistant …

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells

N Ji, Y Yang, CY Cai, ZN Lei, JQ Wang, P Gupta… - Cancer letters, 2019 - Elsevier
Overexpression of ATP-binding cassette (ABC) transporters is one of the most important
mechanisms responsible for the development of multidrug resistance (MDR). Selonsertib, a …

[HTML][HTML] Multidrug resistance proteins (MRPs) and cancer therapy

YK Zhang, YJ Wang, P Gupta, ZS Chen - The AAPS journal, 2015 - Springer
The ATP-binding cassette (ABC) transporters are members of a protein superfamily that are
known to translocate various substrates across membranes, including metabolic products, …

[HTML][HTML] Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India

…, PP Singh, PK Dubey, A Pathak, P Gupta… - Frontiers in …, 2020 - frontiersin.org
Studies on host-pathogen interaction have identified human ACE2 as a host cell receptor
responsible for mediating infection by coronavirus (COVID-19). Subsequent studies have …

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

YF Fan, W Zhang, L Zeng, ZN Lei, CY Cai, P Gupta… - Cancer letters, 2018 - Elsevier
The development of multidrug resistance (MDR) to chemotherapy remains a major challenge
in the treatment of cancer. Numerous mechanisms have been recognized that cause MDR, …

[HTML][HTML] CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis

P Gupta, PK Sharma, H Mir, R Singh, N Singh… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Poor clinical outcome of lung cancer (LuCa) is primarily due to lack of knowledge about
specific molecules involved in its progression and metastasis. In this study, we for the first time …